Your browser doesn't support javascript.
loading
Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: a retrospective analysis.
Suminokura, Jin; Miyamoto, Morikazu; Yoshikawa, Tomoyuki; Kouta, Hiroko; Kikuchi, Yoshihiro; Hada, Taira; Ishibashi, Hiroki; Ito, Tsubasa; Iwahashi, Hideki; Kakimoto, Soichiro; Suzuki, Rie; Matsuura, Hiroko; Kishimoto, Naohisa; Takano, Masashi.
Afiliación
  • Suminokura J; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.
  • Miyamoto M; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan. morikazu1118@hotmail.co.jp.
  • Yoshikawa T; Department of Clinical Oncology, National Defense Medical College Hospital, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.
  • Kouta H; Department of Gynecology, Ohki Memorial Kikuchi Cancer Clinic for Women, 111-1, Arahata, Tokorozawa, Saitama, 359-1133, Japan.
  • Kikuchi Y; Department of Gynecology, Ohki Memorial Kikuchi Cancer Clinic for Women, 111-1, Arahata, Tokorozawa, Saitama, 359-1133, Japan.
  • Hada T; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.
  • Ishibashi H; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.
  • Ito T; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.
  • Iwahashi H; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.
  • Kakimoto S; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.
  • Suzuki R; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.
  • Matsuura H; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.
  • Kishimoto N; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.
  • Takano M; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.
BMC Cancer ; 22(1): 176, 2022 Feb 16.
Article en En | MEDLINE | ID: mdl-35172766
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Carcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Bevacizumab / Antineoplásicos Inmunológicos Tipo de estudio: Evaluation_studies / Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Carcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Bevacizumab / Antineoplásicos Inmunológicos Tipo de estudio: Evaluation_studies / Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido